NucleoTech
Manufacturing · Israel · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Prof. H. Oppenheimer St, Rehovot, Cent...Website
www.nucleo-tech.comRevenue
$5.2 MillionIndustry
About NucleoTech
Is NucleoTech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when NucleoTech launches new products
NucleoTech, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if NucleoTech had a recent Job posting/layoffs
Check if NucleoTech has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if NucleoTech is spiking on competitors!
Funding: Get notified immidiatlly once NucleoTech has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on NucleoTech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at NucleoTech
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
NucleoTech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NucleoTech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NucleoTech.
NucleoTech Tech Stack
A closer look at the technologies used by NucleoTech
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NucleoTech
NucleoTech specializes in innovative drug delivery solutions aimed at overcoming the blood-brain barrier, which hinders effective treatment for brain diseases. Their proprietary BrainPortal carriers enable therapeutic antibodies and oligonucleotides to reach the brain safely and non-invasively. The company employs a direct in vivo screening platfor... Read More